Koordination und Qualität im Gesundheitswesen

Lagerløv, P., Veninga, C.C.M., Muskova, M., Hummers-Pradier, E., Stålsby Lundborg, C.,
Andrew, M., Haaijer-Ruskamp, F.M. on behalf of the Drug Education Project (DEP) group
(2000): Asthma management in five European countries: doctors’ knowledge, attitudes and
prescribing behaviour. European Respiratory Journal, Vol. 15, S. 25-29.
Lauterbach, K.W. und Volmer, T. (Hrsg.) (2002): Arzneimitteltherapie – Über-, Unter- und
Fehlversorgung, Stuttgart/New York.
Law, M.R., Wald, N.J., Morris, J.K. and Jordan, R.E. (2003): Value of low-dose combination
treatment with blood pressure lowering drugs: analysis of 354 randomised trials, British
Medical Journal, Vol. 326, S. 1427-1436.
Lexchin, J. (1997): What information do physicians receive from pharmaceutical representatives?
Canadian Family Physician, Vol. 43, S. 941-945.
Lexchin, J. (1998): Improving the appropriateness of physician prescribing. International Journal
of Health Services, Vol. 28, Nr. 2, S. 253-267.
Lexchin, J., Bero, L.A., Djulbergovic, B. and Clark, O. (2003): Pharmaceutical industry
sponsorship and research outcome and quality: systematic review. British Medical Journal,
Vol. 326, S. 1167- 1177.
Lichtenberg, F.R. (2001): Are the benefits of newer drugs worth their cost? Evidence from the
1996 MEPS. Health Affairs. Vol. 20, S. 241-251.
Lyles, A. and Palumbo, F.B. (1999): The Effect of Managed care on Prescription Drug Costs
and Benefits. Pharmacoeconomics, Vol. 15(2), S: 129-140.
Maisel A.S., Krishnaswamy, P., Nowak, R.M., McCord, J., Hollander, J.E., Duc, P., Omland,
T., Storrow, A.B., Abraham, W.T., Wu, A.H., Clopton, P., Steg, P.G., Westheim, A.,
Knudsen, C.W., Perez, A., Kazanegra, R., Herrmann, H.C. and McCullough, P.A. (2002):
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
New England Journal of Medicine, Vol. 347, S. 161-167.
Märkischer Kreis (2003): Information des Amtsapothekers und der Heimaufsicht. Umgang mit
Arzneimitteln in Heimen, die unter das Heimgesetz fallen, Lüdenscheid,
http://www.maerkischer-kreis.de/soziales/arzneimittel_in_heimen.pdf.
Martens, H. (2004): Verlagerung des Kampfgebiets. Der Spiegel, Heft 86.
Maschewsky-Schneider, U. (1997): Frauen sind anders krank: zur gesundheitlichen Lage der
Frauen in Deutschland, Weinheim.
Maschewsky-Schneider, U., Babitsch, B. und Ducki, A. (2003): Geschlecht und Gesundheit, in:
Hurrelmann, K. und Laaser, U. (Hrsg.): Handbuch Gesundheitswissenschaften, Weinheim.
Masoudi, F.A., Havranek, E.P., Wolfe, P., Gross, C.P., Rathore, S.S., Stone, J.F., Ordin, D.L.,
and Krumholz, H.M. (2003): Most hospitalized older persons do not meet the enrollment
criteria for clinical trials in heart failure. American Heart Journal, Vol. 146, S. 250-257.
Mayer, K.U. und Wagner, M. (1996): Lebenslagen und soziale Ungleichheit im hohen Alter, in:
Mayer, K.U. und Baltes, P.B. (Hrsg.): Die Berliner Altersstudie, Berlin, S. 251-275.
Mayor, S. (2002): NICE estimates that its recommendations have cost the NHS GBP 575m,
British Medical Journal, Vol.325, S. 924.
McMurray, J.J., Ostergren, J., Swedberg, K., Granger, C.B., Held, P., Michelson, E.L.,
Olofsson, B., Yusuf, S. and Pfeffer, M.A. (2003): Effects of candesartan in patients with
chronic heart failure and reduced left-ventricular systolic function taking angiotensinconverting-enzyme-inhibitors:
the CHARM-Added trial. Lancet, Vol. 362, S. 767-771.
750